172 related articles for article (PubMed ID: 36057091)
1. Impacts of price changes on public hospital reforms in China: evidence from 25 million patients at tertiary hospitals.
Zhu D; Shi X; Chen S; Ye X; He P
Health Policy Plan; 2022 Nov; 37(10):1307-1316. PubMed ID: 36057091
[TBL] [Abstract][Full Text] [Related]
2. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
Zhu D; Shi X; Nicholas S; Bai Q; He P
BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
[TBL] [Abstract][Full Text] [Related]
3. Variations in the impact of the new case-based payment reform on medical costs, length of stay, and quality across different hospitals in China: an interrupted time series analysis.
Tang X; Zhang X; Chen Y; Yan J; Qian M; Ying X
BMC Health Serv Res; 2023 Jun; 23(1):568. PubMed ID: 37264450
[TBL] [Abstract][Full Text] [Related]
4. Effect of healthcare system reforms on public hospitals' revenue structures: Evidence from Beijing, China.
Gao L; Shi L; Meng Q; Kong X; Guo M; Lu F
Soc Sci Med; 2021 Aug; 283():114210. PubMed ID: 34274783
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals.
Zhang X; Zimmerman A; Lai H; Zhang Y; Tang Z; Tang S; Ogbuoji O
Front Public Health; 2024; 12():1229722. PubMed ID: 38721544
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
Lin T; Wu Z; Liu M; Wu X; Zhang X
Int J Equity Health; 2020 Aug; 19(1):133. PubMed ID: 32762691
[TBL] [Abstract][Full Text] [Related]
7. Intended and unintended impacts of the comprehensive reform of urban public hospitals: A mixed-method study in Hangzhou, China.
Zhang T; Liu J; Lu B; Yan Z; Huang X; Lu W
Front Public Health; 2022; 10():979455. PubMed ID: 36299745
[TBL] [Abstract][Full Text] [Related]
8. The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.
Zhang X; Lai H; Zhang L; He J; Fu B; Jin C
BMC Health Serv Res; 2020 Nov; 20(1):1058. PubMed ID: 33225941
[TBL] [Abstract][Full Text] [Related]
9. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
[TBL] [Abstract][Full Text] [Related]
10. Intended and unintended impacts of price changes for drugs and medical services: Evidence from China.
Fu H; Li L; Yip W
Soc Sci Med; 2018 Aug; 211():114-122. PubMed ID: 29935401
[TBL] [Abstract][Full Text] [Related]
11. Deregulation and pricing of medical services: a policy experiment based in China.
Zang W; Zhou M; Zhao S
BMC Health Serv Res; 2021 May; 21(1):501. PubMed ID: 34034722
[TBL] [Abstract][Full Text] [Related]
12. What is the major driver of China's hospital medical expenditure growth? A decomposing analysis.
Yan X; Liu Y; Rao K; Li J
BMJ Open; 2022 Feb; 12(2):e048308. PubMed ID: 35135761
[TBL] [Abstract][Full Text] [Related]
13. Effect of a typical systemic hospital reform on inpatient expenditure for rural population: the Sanming model in China.
Meng Z; Zhu M; Cai Y; Cao X; Wu H
BMC Health Serv Res; 2019 Apr; 19(1):231. PubMed ID: 30992013
[TBL] [Abstract][Full Text] [Related]
14. Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province.
Zhang H; Hu H; Wu C; Yu H; Dong H
PLoS One; 2015; 10(11):e0143130. PubMed ID: 26588244
[TBL] [Abstract][Full Text] [Related]
15. Impact of Medical-Pharmaceutical Separation Reform on Hospitalization Expenditure in Tertiary Public Hospitals: Difference-in-Difference Analysis Based on Panel Data from Beijing.
Wang W; Liang J; Fan R; Cai Y; Yin B; Hu Y
Risk Manag Healthc Policy; 2024; 17():1263-1276. PubMed ID: 38770149
[TBL] [Abstract][Full Text] [Related]
16. The impacts of diagnosis-intervention packet payment on the providers' behavior of inpatient care-evidence from a national pilot city in China.
Ding Y; Yin J; Zheng C; Dixon S; Sun Q
Front Public Health; 2023; 11():1069131. PubMed ID: 37325323
[TBL] [Abstract][Full Text] [Related]
17. Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis.
Zang X; Zhang M; Wei S; Tang W; Jiang S
BMC Health Serv Res; 2019 Jul; 19(1):512. PubMed ID: 31337396
[TBL] [Abstract][Full Text] [Related]
18. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
[TBL] [Abstract][Full Text] [Related]
19. The impacts of public hospital comprehensive reform policies on hospital medicine cost, revenues and healthcare expenditures 2014-2019: An analysis of 103 tertiary public hospitals in China.
Pan L; Xiao K; Zhu H; Luo L
Front Health Serv; 2023; 3():1079370. PubMed ID: 36926494
[TBL] [Abstract][Full Text] [Related]
20. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing.
Tang W; Xie J; Lu Y; Liu Q; Malone D; Ma A
J Med Econ; 2018 Apr; 21(4):326-339. PubMed ID: 29139303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
